Decoding the 2026 MPFS Final Rule: What Radiation Oncologists Need to Know
The 2026 Medicare Physician Fee Schedule Final Rule brings the most significant changes to radiation oncology reimbursement in over a decade. In this episode, Adam Greathouse, JD, ASTRO Director of Health Policy, and Amar Rewari, MD, MBA, FASTRO, ASTRO Health Policy Council Chair, Chief of Radiation Oncology for Luminis Health, break down what radiation oncologists need to know, from the overhaul of treatment delivery codes to CMS’s new efficiency adjustment. Whether you’re a physician or administrator this episode offers practical insights to help you prepare for these changes.
Duration:
20:20
Navigating Prior Authorization: Real-life Experiences
In the latest episode of the RadOnc Report, ASTRO Early Career Committee Vice-chair Avinash Chaurasia, MD, interviewed Ben Durkee, MD, from the University of Wisconsin and Join Luh, MD, FASTRO, a community practice radiation oncologist at St. Joseph Hospital about the impact of prior authorization on their day-to-day practice and how prior authorization is handled administratively in both university and private practice settings.
Duration:
36:42
World Radiation Therapy Awareness Day (WRAD)
Description +
In this episode, hear about the first annual World Radiation Therapy Awareness Day and how the radiation oncology community can be a part of education effort.
00:00
Medicare Payment Proposed Rules 2026 Updates
Description +
In this episode, ASTRO Vice President of Advocacy Dave Adler is interviewed by Avery Adler regarding the recent Medicare Payment Rules for 2026.
00:00
Navigating Multidisciplinary Care
Description +
In this episode, a radiation oncologist, medical oncologist and surgical oncologist discuss how and why to build multidisciplinary collaborations.
00:00
An Interview with Dr. Neha Vapiwala on ASTRO participation
Description +
In this episode, Drs. Keole and Vapiwala talk about the importance of becoming involved in ASTRO and shared how they ended up in their roles at ASTRO.
00:00
ASTRO’s Role as an Advocate Organization
Description +
RadOnc Report Episode 1
00:00
